Sensitivity of tumor cells to the cyclin dependent kinase (CDK) inhibitor flavopiridol (FLAVO) correlates to loss of bcl-2 expression Meeting Abstract


Authors: Schwartz, G. K.; Farsi, K.; Makhija, S.; Konig, A.; Gabrilove, J. L.; Spriggs, D.
Abstract Title: Sensitivity of tumor cells to the cyclin dependent kinase (CDK) inhibitor flavopiridol (FLAVO) correlates to loss of bcl-2 expression
Meeting Title: 88th Annual Meeting of the American Association for Cancer Research
Keywords: tumor biology; flavopiridol; cyclin d1; cyclin-dependent kinase; pharmacology; antineoplastic-drug; enzyme inhibitor-drug; mkn-74 cell line; decreased transcription; human gastric cancer cells; human ovarian cancer cells; ov532 cell line; 183cll cell line
Journal Title: Proceedings of the American Association for Cancer Research Annual Meeting
Volume: 38
Meeting Dates: 1997 Apr 12-16
Meeting Location: San Diego, CA
ISSN: 0197-016X
Publisher: American Association for Cancer Research  
Date Published: 1997-03-01
Start Page: 472
End Page: 473
Language: English
ACCESSION: BCI:BCI199799532560
PROVIDER: biosis
Notes: Meeting abstract: 3160 -- Source: Biosis
MSK Authors
  1. Gary Schwartz
    385 Schwartz
  2. David R Spriggs
    325 Spriggs
  3. Janice Gabrilove
    122 Gabrilove
  4. Sharmila K Makhija
    13 Makhija
  5. Andrea H Koenig
    16 Koenig